Two patients with suggestive [18F]FDG uptake in ultimately noncancerous lesions did not show HER2 tracer uptake above the blood-pool activity in these lesions (patient 14, inflammation around breast prosthesis; patient 13, tuberculosis) (Supplemental Fig. 1). This evidence concerns the gene ERBB2 and tuberculosis.